Exercise: Is it a neuroprotective and if so, how does it work?

Parkinsonism and Related Disorders

Volumn 20, Issue SUPPL.1, 2014, Pages

  Zigmond, Michael J ^a   Smeyne, Richard J ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

6 OHDA; Environmental enrichment; Exercise; Mice; MPTP; Neuroprotection; Neurotrophic factors; Rats

Indexed keywords

DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NEUROTOXIN; NEUROTROPHIC FACTOR;

ARTICLE; BRAIN REGION; CELL LOSS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOPAMINERGIC NERVE CELL; EXERCISE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

6-OHDA; ENVIRONMENTAL ENRICHMENT; EXERCISE; MICE; MPTP; NEUROPROTECTION; NEUROTROPHIC FACTORS; RATS;

ANIMALS; DISEASE MODELS, ANIMAL; EXERCISE; HUMANS; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE;

EID: 84887926609     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/S1353-8020(13)70030-0     Document Type: Article

References (30)

1. Moore DJ, West AB, Dawson VL, Dawson TM Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci 2005, 28:57-87.
2. Blandini F Neural and immune mechanisms in the pathogenesis of Parkinson's disease. J Neuroimmune Pharmacol 2013, 8:189-201.
3. Gerlach M, Riederer P Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. J Neural Transm 1996, 103:987-1041.
4. Bove J, Perier C Neurotoxin-based models of Parkinson's disease. Neuroscience 2012, 211:51-76.
5. Rosenzweig MR Modification of brain circuits through experience. From neural plasticity and memory: from genes to brain imaging 2007, Taylor & Francis Group, LLC, Boca Raton, FL. F. Bermudez-Rattoni (Ed.).
6. van Praag H, Kempermann G, Gage FH Neural consequences of environmental enrichment. Nat Rev Neurosci 2000, 1:191-198.
7. Nithianantharajah J, Hannan AJ Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat Rev Neurosci 2006, 7:697-709.
8. Goodwin VA, Richards SH, Taylor RS, Taylor AH, Campbell JL The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis. Mov Disord 2008, 23:631-640.
9. Xu Q, Park Y, Huang X, Hollenbeck A, Blair A, Schatzkin A, et al. Physical activities and future risk of Parkinson disease. Neurology 2010, 75:341-348.
10. Chen H, Zhang SM, Schwarzschild MA, Hernán MA, Ascherio A Physical activity and the risk of Parkinson disease. Neurology 2005, 64:664-669.
11. Tillerson JL, Cohen AD, Philhower J, Miller GW, Zigmond MJ, Schallert T Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxy-dopamine. J Neurosci 2001, 21:4427-4435.
12. Jadavji NM, Kolb B, Metz GA Enriched environment improves motor function in intact and unilateral dopamine-depleted rats. Neuroscience 2006, 140:1127-1138.
13. Mabandla M, Kellaway L, St Clair Gibson A, Russell VA Voluntary running provides neuroprotection in rats after 6-hydroxydopamine injection into the medial forebrain bundle. Metab Brain Dis 2004, 19:43-50.
14. O'Dell SJ, Gross NB, Fricks AN, Casiano BD, Nguyen TB, Marshall JF Running wheel exercise enhances recovery from nigrostriatal dopamine injury without inducing neuroprotection. Neuroscience 2007, 144:1141-1151.
15. Steiner B, Winter C, Hosman K, Siebert E, Kempermann G, Petrus DS, et al. Enriched environment induces cellular plasticity in the adult substantia nigra and improves motor behavior function in the 6-OHDA rat model of Parkinson's disease. Exp Neurol 2006, 199:291-300.
16. Fisher BE, Petzinger GM, Nixon K, Hogg E, Bremmer S, Meshul CK, et al. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia. J Neurosci Res 2004, 77:378-390.
17. Gerecke KM, Jia Y, Pani A, Pagala V, Smeyne RY Exercise protects against MPTP-induced neurotoxicity in mice. Brain Res 2010, 1341:72-83.
18. Zigmond MJ, Abercrombie ED, Berger TW, Grace AA, Stricker EM Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci 1990, 13:290-296.
19. Bezard E, Dovero S, Belin D, Duconger S, Jackson-Lewis V, Przedborski S, et al. Enriched environment confers resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and cocaine: involvement of dopamine transporter and trophic factors. J Neurosci 2003, 23:10999-11007.
20. Anstrom KK, Schallert T, Woodlee MT, Shattuck A, Roberts DC Repetitive vibrissae-elicited forelimb placing before and immediately after unilateral 6-hydroxydopamine improves outcome in a model of Parkinson's disease. Behav Brain Res 2007, 179:183-191.
21. Cohen AD, Zigmond MJ, Smith AD Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: time course of protection and neurorestoration. Brain Res 2011, 1370:80-88.
22. Bezard E, Gross CE, Brotchie JM Presymptomatic compensation in Parkinson's disease is not dopamine-mediated. Trends Neurosci 2003, 26:215-221.
23. Faherty CJ, Raviie Shepherd K, Herasimtschuk A, Smeyne RJ Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism. Brain Res Mol Brain Res 2005, 134:170-179.
24. Leak RK, Liou AK, Zigmond MJ Effect of sublethal 6-hydroxydopamine on the response to subsequent oxidative stress in dopaminergic cells: evidence for preconditioning. J Neurochem 2006, 99:1151-1163.
25. Pattarini R, Rong Y, Shepherd KR, Jiao Y, Qu C, Smeyne RJ, et al. Long-lasting transcriptional refractoriness triggered by a single exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine. Neuroscience 2012, 214:84-105.
26. Cotman CW, Berchtold NC, Christie LA Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci 2007, 30:464-472.
27. Hoffer BJ, Hoffman A, Bowenkamp K, Huettl P, Hudson J, Martin D, et al. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci Lett 1994, 182:107-111.
28. Boger HA, Middaugh LD, Huang P, Zaman V, Smith AC, Hoffer BJ, et al. A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra. Exp Neurol 2006, 202:336-347.
29. Siegel GJ, Chauhan NB Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res Rev 2000, 33:199-227.
30. Gill SS, Patel NK, Hotton GR, O'Sullivan K, McCarter R, Bunnage M, et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 2003, 9:589-595.